Bicocca Open Archive

Logo unimib boa
PIAZZA, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.512
AS - Asia 5.351
EU - Europa 4.804
SA - Sud America 706
AF - Africa 71
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.486
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.277
SG - Singapore 1.616
IT - Italia 1.201
CN - Cina 1.179
VN - Vietnam 1.145
HK - Hong Kong 739
RU - Federazione Russa 622
DE - Germania 607
BR - Brasile 544
SE - Svezia 517
IE - Irlanda 378
GB - Regno Unito 335
UA - Ucraina 258
CA - Canada 181
JP - Giappone 167
FR - Francia 160
FI - Finlandia 141
AT - Austria 114
NL - Olanda 112
IN - India 100
ES - Italia 86
KR - Corea 82
AR - Argentina 70
TR - Turchia 69
PL - Polonia 51
DK - Danimarca 50
ID - Indonesia 49
BE - Belgio 40
CH - Svizzera 40
MX - Messico 37
AU - Australia 32
IR - Iran 32
TW - Taiwan 32
CL - Cile 31
ZA - Sudafrica 31
BD - Bangladesh 29
EC - Ecuador 24
GR - Grecia 21
IQ - Iraq 18
PT - Portogallo 17
TH - Thailandia 12
LT - Lituania 10
NO - Norvegia 10
OM - Oman 10
VE - Venezuela 9
CO - Colombia 8
PH - Filippine 8
PY - Paraguay 8
SA - Arabia Saudita 8
KE - Kenya 7
MY - Malesia 7
UZ - Uzbekistan 7
JO - Giordania 6
PK - Pakistan 6
SI - Slovenia 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
EU - Europa 5
LB - Libano 5
MA - Marocco 5
PE - Perù 5
TN - Tunisia 5
UY - Uruguay 5
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
AL - Albania 3
AZ - Azerbaigian 3
CR - Costa Rica 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
RE - Reunion 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LY - Libia 2
PA - Panama 2
RS - Serbia 2
SC - Seychelles 2
CI - Costa d'Avorio 1
GH - Ghana 1
HR - Croazia 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 18.481
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.468
Singapore 984
Hong Kong 727
Ashburn 579
Woodbridge 490
Milan 489
Houston 362
Dublin 356
Ho Chi Minh City 355
Chandler 309
Frankfurt am Main 308
Jacksonville 298
Hanoi 289
Wilmington 271
Santa Clara 230
Fairfield 228
New York 207
Dearborn 205
Beijing 150
Los Angeles 146
Princeton 144
Hefei 143
Dallas 140
Seattle 119
Nanjing 115
Vienna 99
Cambridge 90
Munich 89
The Dalles 86
São Paulo 68
Chicago 67
Buffalo 66
Shanghai 65
Moscow 64
Seoul 60
Helsinki 57
Lachine 55
Guangzhou 46
Tokyo 44
Jakarta 41
Lawrence 38
London 38
Rome 38
Boardman 37
Council Bluffs 37
Dong Ket 37
Warsaw 35
Da Nang 34
Nanchang 33
Altamura 31
Boydton 27
Denver 27
Ha Long 27
Toronto 27
Haiphong 26
Rio de Janeiro 26
Brussels 25
Montreal 25
Paris 25
Andover 23
Boston 23
Hiroshima 23
Santiago 23
Shenyang 23
Bologna 22
Hải Dương 22
Jinan 22
Nuremberg 22
San Diego 22
Brooklyn 21
Falls Church 21
Kent 21
Ottawa 21
Quận Bình Thạnh 21
Bari 20
Orem 20
Biên Hòa 19
Changsha 19
Lambeth 19
San Jose 19
Tianjin 19
Amsterdam 18
Atlanta 18
Can Tho 18
Hebei 18
Madrid 18
Ninh Bình 18
Florence 17
Barcelona 16
Hangzhou 16
Naples 16
Bắc Ninh 15
Norwalk 15
Poplar 15
Hyderabad 14
Lausanne 14
Stockholm 14
Vũng Tàu 14
Washington 14
Zhengzhou 14
Totale 11.469
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization 988
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? 662
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 494
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 455
Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation 447
Feasibility of a standard cognitive assessment in European academic memory clinics 438
Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy 432
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 388
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 376
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 373
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 372
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 320
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 310
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 295
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 288
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 260
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 254
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 253
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 252
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 248
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 238
Ricerca quantitativa di Epstein-barr virus in campioni di liquor e sangue da pazienti affetti da sclerosi multipla 236
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 236
Cerebral Amyloid Angiopathy-Related Inflammation 235
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 228
Biological markers of vascular damage in Alzheimer’s disease patients 219
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 217
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 217
A challenging diagnosis of reversible “vascular” dementia: Cerebral amyloid angiopathy-related inflammation 214
Anti-Aβ autoantibodies in CAA-ri vs AD patients: different singers for the same ARIA? 212
Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology 212
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 211
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 207
Ubiquitin regulates GGA3-mediated degradation of BACE1 204
Pathogenetic role of anti-AB autoantibodies in Cerebral Amyloid Angiopathy-related inflammation and Alzheimer's disease 201
Abrupt withdrawal of immunosuppressive drugs: a potential trigger for CAA-ri 194
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 190
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy 189
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 188
Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review 183
CSF biomarkers for Amyloid Related Imaging Abnormalities (ARIA) in immunotherapy trials of Alzheimer’s disease and Cerebral Amyloid Angiopathy: report from the iCAß International Network 182
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 173
Anti-abeta antibodies in CSF: markers for therapies? 173
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 172
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 171
Iatrogenic CAA-ri supported by ARIA-E, raised CSF anti-Aβ autoantibodies and sTREM2 after COVID-19 vaccination 169
Metodo e kit per la rilevazione di anticorpi 169
Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease 168
BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus. 164
Increased levels of tissue factor pathway inhibitor in cerebrospinal fluid are related to neurodegeneration in alzheimer’s disease patients 162
Pathogenetic similarities shared by Alzheimer's disease and multiple sclerosis 159
Platelets might mediate the increase of plasma glutamate in acute ischemic stroke: Relevance for early neurological deterioration 156
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 154
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 154
CSF anti-Aß autoantibodies as novel biomarker for Cerebral Amyloid Angiopathy-related inflammation: implications for amyloid-related imaging abnormalities (ARIA) during passive immunization in Alzheimer’s disease 152
Autologous anti-Aß antibodies in caa-ri: new biomarker for detection of Amyloid-Related Imaging Abnormalities (ARIA) during Aß-disease modifying therapies for AD 150
Author Response: Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 148
Effect of TNF-alpha on platelet glutamate uptake in Stroke patients 146
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study 142
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 141
A method and a kit for the detection of anti-beta amyloid antibodies 139
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 138
Biomarkers in cerebral amyloid angiopathy-related inflammation 137
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease 136
Symposium Immunotherapy Trials in CAA and AD: The ARIA paradox in AD and CAA: merely an adverse event or an out of tune proof of immunotherapy effectiveness? 134
Inflammatory CAA and AD Biomarkers International Network 131
Cerebrospinal Fluid Anti-Amyloid-Beta; Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation 130
Non-vascular leucoencephalic dementia: The case of Cerebral Amyloid Angiopathy related inflammation 130
Pathogenetic Role of Anti- Aß Autoantibodies in CAA-related Inflammation: Implications for Amyloid-modifying Therapies in AD 129
CAA-ri and ARIA: Two Faces of the Same Coin? 128
Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice 127
Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case 126
Cerebral amyloid angiopathy-related inflammation. report of a case 125
Vascular damage and neurodegeneration 124
Anti-Aß autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease βiomarkers Collaborative Network (iCAβ) 123
Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy? 120
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model 117
The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue 116
Auto-antibodies to Aß in CSF 114
Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease 110
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease 109
Why does ARIA‐E appear bright? A quantitative model linking brain tissue composition and T2 FLAIR hyperintensities 108
Large Collaborative Registries and Real-World Data to Manage Amyloid-Related Imaging Abnormalities 108
Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) 107
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 105
Données récentes sur l’Amyloïdose Cérébrale Inflammatoire. 104
Anti-Amyloid Treatments: A Therapeutic Revolution, Ready for Europe 99
Analytical Validation of a pre-Industrial Prototype Assay for Anti-Aβ Autoantibody ultrasensitive quantification in patients with CAA-ri and ARIA-E of Alzheimer’s disease Immunotherapy 93
Anti-Aß autoantibodies and endothelial damage during spontaneous Amyloid-Related Imaging Abnormalities (ARIA): report from the inflammatory cerebral amyloid angiopathy and alzheimer's disease biomarkers collaborative network (iCAB) 90
The inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease Biomarkers International Network (iCAβ) initiative 86
Inflammatory CAA mechanisms and biomarkers– lessons for sporadic CAA diagnosis and treatment 84
Abstract W MP89: Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 83
Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services 68
Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies 55
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 51
Microbiota-gut-brain axis dysregulation in Alzheimer’s disease and its modulation through probiotic supplementation 39
Mass Spectrometry Imaging in the clinical setting: do pretty images hold diagnostic potential? 38
Totale 19.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021762 0 0 0 0 0 80 120 82 126 135 78 141
2021/20221.039 96 86 114 97 74 106 33 31 42 76 74 210
2022/20231.727 204 419 146 146 147 232 96 91 172 16 37 21
2023/20241.316 44 67 59 62 180 274 229 82 133 32 39 115
2024/20253.696 164 421 317 135 297 179 277 202 382 463 291 568
2025/20266.123 1.434 862 773 1.142 1.232 680 0 0 0 0 0 0
Totale 19.302